TelyRx Holdings Inc. TELY
TSX · Kanada · Sağlık Hizmetleri
CAD 2,55+0,15 (+%6,25)
Piyasa kapalı· · CAD · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Piyasa kapalı· · CAD · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
Boulder, Colorado--(Newsfile Corp. - September 14, 2026) - TN Group Volunteers Ltd. (the "Company"), a company wholly-owned by Benjamin Atkins (the "Acquiror") has filed on SEDAR+ (www.sedarplus.ca) an early warning report dated September 14, 2026 with respect to subordinate voting shares (the "SVS") in the capital of TelyRx Holdings Inc. (the "Issuer" or "TelyRx").On September 11, 2026, the Company purchased 912,933 SVS at a price of $2.59 per SVS pursuant to a block trade arrangement with a...
Clearwater, Florida--(Newsfile Corp. - August 10, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a technology-enabled healthcare and digital pharmacy platform, today announced financial results for the second quarter ended June 30, 2026. All dollar amounts are expressed in U.S. dollars.Highlights for the Second Quarter of 2026Revenue increased to $22.7 million, compared to $9.3 million in Q2 2025Total Income (Loss) from Operations increased to $5.4 million,.
TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF), a technology-enabled healthcare and digital pharmacy platform, today announced the launch of its new brand platform and digital experience, designed around the needs of modern patients. Shaped by insights gathered from patients over the past two years, the launch represents a significant investment in building a healthcare brand focused on making everyday medication easier to access. Patients can visit the new TelyRx.com website today to order man
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.